Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia
NCT02314663 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358
Last updated 2014-12-11
Summary
Background In subjects with hypercholesterolaemia, cholesterol values remain above guideline levels. One of the limiting factors to the achievement of goals in such patients is therapeutic non-adherence. The aim of this study is to assess the effectiveness of an intervention designed to improve control of hypercholesterolaemic patients, consisting of a combined strategy that would include the delivery of printed information, treatment-compliance check cards and the dispatch of text messages as complementary measures in support of the intervention at the general practitioner's practice.
Methods/Design A randomised, parallel-group clinical trial will be conducted at the family medicine outpatient facilities of eight health centres in three of Spain's Autonomous Regions, covering a total of 358 subjects aged 18 years or over with diagnosis of hypercholesterolaemia. Patients in the intervention group will be supplied with printed material with information on the disease and its management, mobile-telephone text messages with guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance, and self-report cards to check compliance with recommendations. Both groups -intervention and control- will receive routine recommendations from their physicians in accordance with current European clinical practice guidelines for hypercholesterolaemia and cardiovascular risk management. As regards the measurements to be made, the main variable is the proportion of subjects who attain the low density lipoprotein cholesterol levels set as a target across a follow-up period of 24 months. The secondary variables are as follows: adherence to recommendations on lifestyle and adherence to drug treatment; variation in lipid profiles and cardiovascular risk levels; appearance of cardiovascular events; physical activity; food consumption; smoking habit; anthropometric measures; blood pressure; health problems; use of hypolipidaemic agents; socio-demographic data; beliefs and expectations about preventive recommendations; and degree of satisfaction with the combined strategy.
Discussion Should this intervention prove effective, a recommendation could be issued on the application of this combined strategy to subjects with hypercholesterolaemia. It is a simple, relatively inexpensive intervention.
Conditions
- Hypercholesterolemia
- Medication Adherence
- Primary Health Care
Interventions
- DEVICE
-
"COMBINED STRATEGY"
Participants in the intervention group will be supplied with: a) "printed matter" containing information on the disease and its management (this will be handed out at each of the follow-up visits); b) "mobile-telephone text messages" containing guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance (in the periods between visits); and, c) "self-report cards" to check compliance with recommendations (across the entire follow-up).
Sponsors & Collaborators
-
Instituto de Salud Carlos III
collaborator OTHER_GOV -
Gerencia de Atención Primaria, Albacete
lead OTHER
Principal Investigators
-
Ignacio Párraga-Martínez, PhD · Health Care Service of Castilla-La Mancha
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe
NCT05559606 ·Status: COMPLETED
-
Statins at the Primary Care Level
NCT02380911 ·Status: COMPLETED ·Phase: NA
-
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
NCT00651963 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
NCT06262685 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
NCT00723723 ·Status: COMPLETED
-
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
NCT00143676 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3015014 in Participants With High Cholesterol
NCT01890967 ·Status: COMPLETED ·Phase: PHASE2
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536965 ·Status: COMPLETED
-
A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)
NCT02460159 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
NCT02304926 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
NCT00686010 ·Status: COMPLETED ·Phase: PHASE2
-
Sitosterolemia Extension Study (0653-003)(COMPLETED)
NCT00092807 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)
NCT00092586 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
NCT00092625 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol
NCT00185107 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)
NCT00092716 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes
NCT00299169 ·Status: TERMINATED ·Phase: PHASE4
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536796 ·Status: COMPLETED
-
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon
NCT01614561 ·Status: COMPLETED
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
NCT01218204 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
NCT01078285 ·Status: COMPLETED
-
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
NCT02550288 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
NCT00673660 ·Status: COMPLETED